We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.02B
AUM Growth
+$513M
Cap. Flow
+$460M
Cap. Flow %
22.74%
Top 10 Hldgs %
21.5%
Holding
481
New
197
Increased
58
Reduced
57
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 7.95%
2 Industrials 7.82%
3 Consumer Discretionary 5.99%
4 Communication Services 5.9%
5 Consumer Staples 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
226
eBay
EBAY
$50.3B
$1.52M 0.08%
45,300
+24,000
+113% +$780K
FG
227
DELISTED
FGL Holdings Ordinary Shares
FG
$1.5M 0.07%
+149,800
New +$1.5M
FDN icon
228
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.92B
$1.5M 0.07%
+17,000
New +$1.46M
IPHI
229
DELISTED
INPHI CORPORATION
IPHI
$1.48M 0.07%
+30,250
New +$1.41M
ACRS icon
230
Aclaris Therapeutics
ACRS
$750M
$1.46M 0.07%
48,875
+6,702
+16% +$193K
MU icon
231
CALL
Micron Technology
MU
$1.02T
$1.45M 0.07%
+50,000
New +$1.22M
ABEO icon
232
Abeona Therapeutics
ABEO
$349M
$1.42M 0.07%
+11,376
New +$1.47M
BMY icon
233
CALL
Bristol-Myers Squibb
BMY
$128B
$1.41M 0.07%
+26,000
New +$1.43M
IP icon
234
International Paper
IP
$22.5B
$1.39M 0.07%
+28,934
New +$1.45M
EXPR
235
CALL
DELISTED
Express, Inc.
EXPR
$1.37M 0.07%
7,500
-20,630
-73% -$4.26M
DNOW icon
236
CALL
DNOW Inc
DNOW
$2.59B
$1.36M 0.07%
+80,000
New +$1.57M
BPMC
237
DELISTED
Blueprint Medicines
BPMC
$1.34M 0.07%
+33,600
New +$1.2M
AVD icon
238
American Vanguard Corp
AVD
$75.2M
$1.33M 0.07%
+80,250
New +$1.33M
LUMO
239
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.33M 0.07%
+6,111
New +$873K
IPI icon
240
CALL
Intrepid Potash
IPI
$461M
$1.29M 0.06%
+75,300
New +$1.46M
ESRX
241
CALL
DELISTED
Express Scripts Holding Company
ESRX
$1.28M 0.06%
+19,500
New +$1.34M
SFM icon
242
CALL
Sprouts Farmers Market
SFM
$7.23B
$1.27M 0.06%
+55,000
New +$1.08M
AVD icon
243
CALL
American Vanguard Corp
AVD
$75.2M
$1.25M 0.06%
+75,000
New +$1.25M
STML
244
DELISTED
Stemline Therapeutics, Inc.
STML
$1.2M 0.06%
140,000
-59,886
-30% -$546K
SNAP icon
245
CALL
Snap
SNAP
$7.6B
$1.18M 0.06%
+52,500
New +$1.16M
GOOG icon
246
Alphabet (Google) Class C
GOOG
$3.99T
$1.16M 0.06%
28,000
-300,000
-91% -$12.3M
AGEN
247
Agenus
AGEN
$255M
$1.15M 0.06%
+15,490
New +$1.23M
ZYNE
248
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.05M 0.05%
52,500
-18,900
-26% -$376K
IWM icon
249
CALL
iShares Russell 2000 ETF
IWM
$80.3B
$1.03M 0.05%
7,500
-25,000
-77% -$3.42M
ATH
250
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$975K 0.05%
+19,500
New +$967K

Similar funds

J. Goldman & Co's Q1 2017 Portfolio in Review

As of Q1 2017, J. Goldman & Co held 481 positions worth $2.02B, up 34% from $1.51B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $460M of net new capital in Q1 2017, opening 197 new positions and adding to 58 existing holdings. Its largest new stake was Time Warner Inc: 345,000 shares worth $33.7M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 6.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was CSX Corp, an estimated $13.1M trimmed.

  • J. Goldman & Co's largest Q1 2017 buy was Time Warner Inc: 345,000 shares worth $33.7M.
  • J. Goldman & Co added most to NXP Semiconductors in Q1 2017, an estimated $17.2M increase.
  • J. Goldman & Co's biggest Q1 2017 reduction was CSX Corp, cutting an estimated $13.1M.
  • J. Goldman & Co fully exited Bath & Body Works in Q1 2017, selling an estimated $27.4M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.02B portfolio in Q1 2017.
  • J. Goldman & Co opened 197 new positions and closed 164 in Q1 2017.
  • J. Goldman & Co's portfolio value rose 34% quarter-over-quarter to $2.02B.

Based on J. Goldman & Co's 13F filing for Q1 2017, filed 15 May 2017.